# Interlace Medical Inc — Form D

Interlace Medical Inc of FRAMINGHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2009-06-17. The offering totals $20.5M, of which $20.5M was reported sold. Industry: Other Health Care.

## Offering

- Filed: 2009-06-17
- Form: D
- Accession: 0001399684-09-000004
- Industry: Other Health Care
- Exemptions: 06
- Total offering: $20.5M
- Amount sold: $20.5M
- Investors: 9
- Date of first sale: 2009-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-103008

## Issuer

- Name: Interlace Medical Inc
- CIK: 0001399684
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2005
- Address: 139 NEWBURY STREET, FRAMINGHAM, MA, 01701
- Phone: 508-875-1343

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| J. Daniel Cole | Director | Newton, MA |
| Kevin G Connors | Director | Hopkinton, MA |
| William H Gruber | Director | Framingham, MA |
| Milton McColl | Director | Los Altos, CA |
| William H Gruber | Executive Officer | Framingham, MA |

## More

- [CIK 1399684 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1399684&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001399684-09-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.